Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 5/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.65 |
| ▸ | MAPT | P10636 | 5/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.59 |
| ▸ | LMNA | P02545 | 3/20 | 0.59 |
| ▸ | HTT | P42858 | 3/20 | 0.59 |
| ▸ | POLB | P06746 | 3/20 | 0.58 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.57 |
| ▸ | CA1 | P00915 | 1/20 | 0.57 |
| ▸ | CA2 | P00918 | 1/20 | 0.57 |
| ▸ | HPGD | P15428 | 1/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.56 |
| ▸ | TGM2 | P21980 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL4185047 | 0.98 | MEN1 (0.62) | MEN1KMT2AMAPTALDH1A1LMNA | |
| SCHEMBL13093172 | 0.91 | MEN1 (0.71) | MEN1KMT2AMAPTALDH1A1LMNA | |
| SCHEMBL30237583 | 0.89 | ALDH1A1 (0.58) | MEN1KMT2AMAPTALDH1A1LMNA | |
| SCHEMBL9018657 | 0.87 | MEN1 (0.71) | MEN1KMT2AMAPTALDH1A1LMNA | |
| SCHEMBL3262054 | 0.86 | MEN1 (0.63) | MEN1KMT2AMAPTALDH1A1LMNA | |
| SCHEMBL1263753 | 0.85 | ALDH1A1 (0.59) | MEN1KMT2AMAPTALDH1A1LMNA | |
| SCHEMBL23811 | 0.84 | KMT2A (0.62) | MEN1KMT2AMAPTALDH1A1LMNA | |
| SCHEMBL6053820 | 0.84 | CA1 (0.52) | MEN1KMT2AMAPTALDH1A1LMNA | |
| SCHEMBL7741358 | 0.84 | MEN1 (0.67) | MEN1KMT2AMAPTALDH1A1LMNA | |
| SCHEMBL4166954 | 0.82 | MEN1 (0.65) | MEN1KMT2AMAPTALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070059758-A1 | Regulators of type-1 tumor necrosis factor receptor and other cytokine receptor shedding | THE GOVERNMENT OF THE USA OF AMERICA, REP. BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2007-03-15 | — | — | US | claimed |
| US-20030215820-A1 | Interleukins; aminopeptidases; blot analysis; drug screening | GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | 2003-11-20 | — | — | US | claimed |
| US-6303360-B1 | CULTURING SPHINGOMONAS; MOLECULAR HYBRIDIZATION; GENETIC ENGINEERING; HYDROLYZES ANILIDES OF ALANINE, GLYCINE, LEUCINE, GLUTAMIC ACID, ASPARTIC ACID, LYSINE, ISOLEUCINE, AND VALINE | NOVOZYMES BIOTECH, INC, | 2001-10-16 | — | — | US | claimed |
| WO-2001064856-A2 | REGULATORS OF TYPE-1 TUMOR NECROSIS FACTOR RECEPTOR AND OTHER CYTOKINE RECEPTOR SHEDDING | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, A S REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEA LTH AND HUMAN SERVICES (US) | 2001-09-07 | — | — | WO | claimed |
| US-6184020-B1 | AMINO ACID AND NUCLEOTIDE SEQUENCE; FOR PRODUCTION OF PROTEIN HYDROLYSATES USED AS FLAVORINGS IN FOODS | NOVO NORDISK BIOTECH, INC. | 2001-02-06 | — | — | US | claimed |
| EP-0496680-B1 | Procedure and medium to identify bacteria of the genus Listeria | BIO MERIEUX (FR) | 1995-09-06 | — | — | EP | claimed |
| US-5330889-A | Colorimetric, fluorescence, enzymatic hydrolysis of substrate | BIO MERIEUX (FR) | 1994-07-19 | — | — | US | claimed |
| EP-0496680-A1 | Procedure and medium to identify bacteria of the genus Listeria | BIO MERIEUX, Société anonyme (FR) | 1992-07-29 | — | — | EP | claimed |
| EP-3724328-B1 | PEPTIDASE AND ITS USES | CENTRE NAT RECH SCIENT (FR) | 2025-08-20 | — | — | EP | disclosed |
| EP-4596689-A1 | ENZYME AGENT AND USE THEREOF | Amano Enzyme Inc. (JP) | 2025-08-06 | — | — | EP | disclosed |
| CN-120092086-A | Enzyme agent and application thereof | 天野酶制品株式会社 | 2025-06-03 | — | — | CN | disclosed |
| CN-119874561-A | Charged ion channel blockers and methods of use thereof | 诺西恩医疗公司 | 2025-04-25 | — | — | CN | disclosed |
| CN-119546618-A | Novel retinoic acid compounds, pharmaceutical compositions comprising the same and uses thereof | 至善生医股份有限公司 | 2025-02-28 | — | — | CN | disclosed |
| EP-4489744-A1 | PHARMACEUTICAL COMPOSITION INCLUDING RETINOIC ACID AND CARBOHYDRATE AND USE THEREOF | Mastery Biotech Co., Ltd. (TW) | 2025-01-15 | — | — | EP | disclosed |
| US-5330889-A | Colorimetric, fluorescence, enzymatic hydrolysis of substrate | BIO MERIEUX (FR) | 1994-07-19 | — | — | US | disclosed |
| EP-0569380-A1 | ACRIDINE DERIVATIVES. | GLAXO LAB SA (FR) | 1993-11-18 | — | — | EP | disclosed |
| EP-0496680-A1 | Procedure and medium to identify bacteria of the genus Listeria | BIO MERIEUX, Société anonyme (FR) | 1992-07-29 | — | — | EP | disclosed |
| WO-1992012132-A1 | ACRIDINE DERIVATIVES | LABORATOIRES GLAXO S.A. (FR) | 1992-07-23 | — | — | WO | disclosed |
| EP-0201811-A1 | 7-Oxabicycloheptane substituted aryl amino prostaglandin analogs and their use in inhibiting platelet aggregation and bronchoconstriction | E.R. Squibb & Sons, Inc. (US) | 1986-11-20 | — | — | EP | disclosed |
| US-4607048-A | 7-oxabicycloheptane substituted aryl amino prostaglandin analogs and their use in inhibiting platelet aggregation and bronchoconstriction | E. R. SQUIBB & SONS, INC. (US) | 1986-08-19 | — | — | US | disclosed |